Enabling Design and Manufacture of Best-in-Class Protein Therapeutics By Cell-Free Production; Concept to Clinical Trials

Use of Cell-Free protein production has several game-changing advantages over conventional cell-based expression for human therapies. Sutro has developed a microbial-based platform to enable the design and production of best-in-class complex proteins-based therapeutics. We'll provide incite into some of the fundamentally critical attributes that have guided the development of the platform that support three clinical development stage oncology therapeutics currently being evaluated in patients.